MA29759B1 - 1h-imidazopyridines a substituant hydroxy et procedes - Google Patents

1h-imidazopyridines a substituant hydroxy et procedes

Info

Publication number
MA29759B1
MA29759B1 MA30694A MA30694A MA29759B1 MA 29759 B1 MA29759 B1 MA 29759B1 MA 30694 A MA30694 A MA 30694A MA 30694 A MA30694 A MA 30694A MA 29759 B1 MA29759 B1 MA 29759B1
Authority
MA
Morocco
Prior art keywords
substituted
methods
imidazopyridines
compounds
hydroxy
Prior art date
Application number
MA30694A
Other languages
English (en)
Inventor
Joseph F Dellaria Jr
William H Moser
Matthew R Radmer
George W Griesgraber
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA29759B1 publication Critical patent/MA29759B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

1H-imidazopyridines à substituant hydroxy et procédés Des 1H-imidazo[4,5-c]pyridine-4-amines à substituant hydroxy, avec un substituant hydroxy en position 2, des compositions pharmaceutiques contenant ces composés, des procédés pour la préparation des composés, des intermédiaires, et des méthodes d'utilisation de ces composés comme immunomodulateurs, pour induire la biosynthèse de cytokines chez des animaux et dans le traitement de maladies comprenant des maladies virales et maladies néoplasiques, sont décrits.
MA30694A 2005-09-02 2008-02-29 1h-imidazopyridines a substituant hydroxy et procedes MA29759B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71370405P 2005-09-02 2005-09-02

Publications (1)

Publication Number Publication Date
MA29759B1 true MA29759B1 (fr) 2008-09-01

Family

ID=37561219

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30694A MA29759B1 (fr) 2005-09-02 2008-02-29 1h-imidazopyridines a substituant hydroxy et procedes

Country Status (20)

Country Link
US (2) US20100152230A1 (fr)
EP (1) EP1924581A1 (fr)
JP (1) JP4584335B2 (fr)
KR (1) KR20080031496A (fr)
CN (1) CN101253173A (fr)
AU (1) AU2006287157A1 (fr)
BR (1) BRPI0615250A2 (fr)
CA (1) CA2620933A1 (fr)
CR (1) CR9781A (fr)
EA (1) EA200800396A1 (fr)
EC (1) ECSP088225A (fr)
IL (1) IL189262A0 (fr)
MA (1) MA29759B1 (fr)
MX (1) MX2008002414A (fr)
NO (1) NO20081393L (fr)
RS (1) RS20080128A (fr)
SV (1) SV2009002832A (fr)
TN (1) TNSN08099A1 (fr)
WO (1) WO2007028129A1 (fr)
ZA (1) ZA200801645B (fr)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265351A1 (en) 2003-04-10 2004-12-30 Miller Richard L. Methods and compositions for enhancing immune response
MXPA06001669A (es) 2003-08-12 2006-04-28 3M Innovative Properties Co Compuestos que contienen imidazo-oxima sustituidos.
NZ545412A (en) 2003-08-27 2008-12-24 Coley Pharm Group Inc Aryloxy and arylalkyleneoxy substituted imidazoquinolines
JP2007504269A (ja) 2003-09-05 2007-03-01 スリーエム イノベイティブ プロパティズ カンパニー Ｃｄ５＋ｂ細胞リンパ腫の治療方法
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
KR101494056B1 (ko) 2003-10-03 2015-02-16 쓰리엠 이노베이티브 프로퍼티즈 컴파니 피라졸로피리딘 및 그의 유사체
EP1673087B1 (fr) 2003-10-03 2015-05-13 3M Innovative Properties Company Imidazoquinolines a substitution alcoxy
CN1906192A (zh) 2003-11-14 2007-01-31 3M创新有限公司 羟胺取代的咪唑环化合物
WO2005048933A2 (fr) 2003-11-14 2005-06-02 3M Innovative Properties Company Composes d'un anneau d'imidazo substitues par oxime
AU2004293078B2 (en) 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
JP2007517035A (ja) 2003-12-29 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン
EP1699788A2 (fr) 2003-12-30 2006-09-13 3M Innovative Properties Company Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle
US8697873B2 (en) 2004-03-24 2014-04-15 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US8541438B2 (en) 2004-06-18 2013-09-24 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006009826A1 (fr) 2004-06-18 2006-01-26 3M Innovative Properties Company Thiazoloquinolines et thiazolonaphtyridines substitues par aryloxy et arylalkyleneoxy
JP5209312B2 (ja) 2004-09-02 2013-06-12 スリーエム イノベイティブ プロパティズ カンパニー １−アルコキシ１ｈ−イミダゾ環系および方法
JP5313502B2 (ja) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
CA2592904C (fr) 2004-12-30 2015-04-07 3M Innovative Properties Company Composes chiraux a cycle [1,2]imidazo[4,5] fusionne
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
CA2602083A1 (fr) 2005-02-09 2006-08-09 Coley Pharmaceutical Group, Inc. Composes cycliques du type thiazalo(4,5-c) substitues par un groupe du type oxime et hydroxylamine et methodes connexes
US20080318998A1 (en) 2005-02-09 2008-12-25 Coley Pharmaceutical Group, Inc. Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines
EP1846405A2 (fr) 2005-02-11 2007-10-24 3M Innovative Properties Company Composes cycliques imidazo 4,5-c substitues par oxime et hydroxylamine et procedes associes
CA2597446A1 (fr) 2005-02-11 2006-08-31 Coley Pharmaceutical Group, Inc. Imidazoquinolines et imidazonaphthyridines substituees
EP1851218A2 (fr) 2005-02-23 2007-11-07 3M Innovative Properties Company Composes d'imidazoquinolines a substitution hydroxyalkyle et procedes
AU2006223634A1 (en) 2005-02-23 2006-09-21 Coley Pharmaceutical Group, Inc. Hydroxyalkyl substituted imidazoquinolines
AU2006216686A1 (en) 2005-02-23 2006-08-31 Coley Pharmaceutical Group, Inc. Method of preferentially inducing the biosynthesis of interferon
CA2602683A1 (fr) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines et analogues associes
CA2602590A1 (fr) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Composes cycliques 1-pyrazolo[3,4-c] substitues comme modulateurs de la biosynthese de cytokine destines au traitement d'infections virales et de maladies neoplastiques
AU2006287270A1 (en) 2005-09-09 2007-03-15 Coley Pharmaceutical Group, Inc. Amide and carbamate derivatives of N-{2-[4-amino-2- (ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods
ZA200803029B (en) 2005-09-09 2009-02-25 Coley Pharm Group Inc Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
WO2007056112A2 (fr) 2005-11-04 2007-05-18 Coley Pharmaceutical Group, Inc. 1h-imidazoquinolines substituees par hydroxy et alcoxy et procedes correspondants
JP2009528989A (ja) 2006-02-17 2009-08-13 ファイザー・リミテッド Ｔｌｒ７変調剤としての３−デアザプリン誘導体
EP1988896A4 (fr) 2006-02-22 2011-07-27 3M Innovative Properties Co Conjugués du modificateur de réponse immune
WO2007106854A2 (fr) 2006-03-15 2007-09-20 Coley Pharmaceutical Group, Inc. 1h-imidazonaphthyridines hydroxy et alcoxy substituées, et procédés associés
WO2008008432A2 (fr) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Composés à cycle [1,2] imidazo [4,5-c] fusionné chiral substitué et procédés correspondants
US8178539B2 (en) 2006-09-06 2012-05-15 3M Innovative Properties Company Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods
US20080149123A1 (en) 2006-12-22 2008-06-26 Mckay William D Particulate material dispensing hairbrush with combination bristles
EP2125792B1 (fr) 2007-02-19 2010-12-01 GlaxoSmithKline LLC Utilisation de dérivés de purine comme immunomodulateurs
EP1997805A1 (fr) * 2007-06-01 2008-12-03 Commissariat à l'Energie Atomique Compositions à activité antiparasite, applications associées au traitement des maladies infectieuses causées par des apicomplexans
CA2707030A1 (fr) * 2007-08-03 2009-02-12 Pfizer Limited Imidazopyridinones
US8802684B2 (en) 2008-08-11 2014-08-12 Glaxosmithkline Llc Adenine derivatives
UA103195C2 (uk) 2008-08-11 2013-09-25 Глаксосмитклайн Ллк Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
JP5519670B2 (ja) 2008-08-11 2014-06-11 グラクソスミスクライン エルエルシー アレルギー性、炎症性及び感染性疾患治療用のプリン誘導体
WO2010018134A1 (fr) 2008-08-11 2010-02-18 Smithkline Beecham Corporation Nouveaux dérivés d’adénine
AU2009333559B2 (en) 2008-12-09 2015-03-12 Gilead Sciences, Inc. Modulators of toll-like receptors
SG178899A1 (en) 2009-08-28 2012-04-27 Array Biopharma Inc Raf inhibitor compounds and methods of use thereof
MX2012004706A (es) 2009-10-22 2012-06-08 Gilead Sciences Inc Derivados de purina o deazapurina utiles para el tratamiento de (inter alia) infecciones virales.
WO2011098451A1 (fr) 2010-02-10 2011-08-18 Glaxosmithkline Llc Dérivés de purine et leurs utilisations pharmaceutiques
LT2606047T (lt) 2010-08-17 2017-04-10 3M Innovative Properties Company Imuninio atsako modifikatoriaus junginio lipidizuotos kompozicijos, sudėtys ir būdai
CA2838023C (fr) 2011-06-03 2019-08-13 3M Innovative Properties Company Hydrazino 1h-imidazoquinoleine-4-amines et conjugues obtenus a partir de celles-ci
EP2717919B1 (fr) 2011-06-03 2016-08-03 3M Innovative Properties Company Lieurs hétérobifonctionnels comportant de segments de polyéthylène glycol et conjugués modificateurs de réponse immunitaire obtenus à partir de ceux-ci
AU2012289042A1 (en) 2011-07-22 2014-03-13 Glaxosmithkline Llc Composition
CN103450198B (zh) * 2012-05-29 2015-07-08 首都医科大学 咪唑并吡啶并咪唑-3-取代乙酸苄酯、其合成、抗肿瘤活性及应用
MX359671B (es) 2012-08-24 2018-10-05 Glaxosmithkline Llc Star Compuestos de pirazolopiridina.
PL2922549T3 (pl) 2012-11-20 2017-11-30 Glaxosmithkline Llc Nowe związki
CA2890201A1 (fr) 2012-11-20 2014-05-30 Glaxosmithkline Llc Nouveaux composes
WO2014081643A1 (fr) 2012-11-20 2014-05-30 Glaxosmithkline Llc Nouveaux composés
JP2017526730A (ja) 2014-09-16 2017-09-14 ギリアード サイエンシーズ， インコーポレイテッド Ｔｏｌｌ様受容体モジュレーターの固体形態
EP3728255B1 (fr) 2017-12-20 2022-01-26 3M Innovative Properties Company Composés imidazo [4,5-c]quinoléine à substitution amide ayant un groupe de liaison à chaîne ramifiée destinés à être utilisés en tant que modificateur de la réponse immunitaire
WO2019209811A1 (fr) 2018-04-24 2019-10-31 Bristol-Myers Squibb Company Agonistes macrocycliques du récepteur 7 de type toll (tlr7)
US11554120B2 (en) 2018-08-03 2023-01-17 Bristol-Myers Squibb Company 1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor
KR20220011685A (ko) 2019-05-22 2022-01-28 길리애드 사이언시즈, 인코포레이티드 Tlr7 조절 화합물과 hiv 백신의 조합
CN115151546A (zh) 2020-01-27 2022-10-04 百时美施贵宝公司 作为Toll样受体7(TLR7)激动剂的C3-取代的1H-吡唑并[4,3-d]嘧啶化合物
WO2021154661A1 (fr) 2020-01-27 2021-08-05 Bristol-Myers Squibb Company Composés 1h-pyrazolo [4,3-d]pyrimidine en tant qu'agonistes du récepteur 7 de type toll (tlr7)
KR20220132594A (ko) 2020-01-27 2022-09-30 브리스톨-마이어스 스큅 컴퍼니 톨-유사 수용체 7 (TLR7) 효능제로서의 1H-피라졸로[4,3-d]피리미딘 화합물
EP4097105A1 (fr) 2020-01-27 2022-12-07 Bristol-Myers Squibb Company Composés 1h-pyrazolo[4,3-d]pyrimidine utiles en tant qu'agonistes du récepteur de type toll 7 (tlr7)
US20230122249A1 (en) 2020-01-27 2023-04-20 Bristol-Myers Squibb Company 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS
KR20220132593A (ko) 2020-01-27 2022-09-30 브리스톨-마이어스 스큅 컴퍼니 톨-유사 수용체 7 (TLR7) 효능제로서의 1H-피라졸로[4,3-d]피리미딘 화합물
US20230144824A1 (en) 2020-01-27 2023-05-11 Bristol-Myers Squibb Company 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS
JP2023512207A (ja) 2020-01-27 2023-03-24 ブリストル－マイヤーズ スクイブ カンパニー トール様受容体７（ＴＬＲ７）アゴニストとしての１Ｈ－ピラゾロ［４，３－ｄ］ピリミジン化合物
JP2023512204A (ja) 2020-01-27 2023-03-24 ブリストル－マイヤーズ スクイブ カンパニー トール様受容体７（ＴＬＲ７）アゴニストとしての１Ｈ－ピラゾロ［４，３－ｄ］ピリミジン化合物
GB202014404D0 (en) * 2020-09-14 2020-10-28 Cambridge Entpr Ltd Method for labelling nucleic acid
CN114805341B (zh) * 2021-01-28 2023-12-08 上海翊石医药科技有限公司 一类芳杂环类化合物及其制备方法和用途
CN117466808B (zh) * 2023-12-27 2024-03-12 烟台新药创制山东省实验室 一种6-烷基-2,4-二羟基吡啶类衍生物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100341341B1 (ko) * 1993-07-15 2002-11-25 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 이미다조[4,5-c]피리딘-4-아민
TW552261B (en) * 1996-07-03 2003-09-11 Japan Energy Corp Novel purine derivative
JP4331944B2 (ja) * 2001-04-17 2009-09-16 大日本住友製薬株式会社 新規アデニン誘導体
PL214231B1 (pl) * 2001-04-27 2013-07-31 Eisai R & D Man Co Pochodne pirazolo [1,5-a] pirydyny, kompozycje je zawierajace oraz zastosowanie
JP2005538057A (ja) * 2002-06-07 2005-12-15 スリーエム イノベイティブ プロパティズ カンパニー エーテル置換イミダゾピリジン
NZ541836A (en) * 2003-02-27 2008-12-24 Palau Pharma Sa Pyrazolopyridine derivatives
US7517887B2 (en) * 2003-04-09 2009-04-14 General Atomics Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
JP2005089334A (ja) * 2003-09-12 2005-04-07 Sumitomo Pharmaceut Co Ltd ８−ヒドロキシアデニン化合物
CN1997642B (zh) * 2003-09-22 2012-06-13 詹森药业有限公司 7-氨基亚烷基-杂环喹诺酮类和萘啶酮类
FR2860514A1 (fr) * 2003-10-03 2005-04-08 Sanofi Synthelabo Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
WO2005048933A2 (fr) * 2003-11-14 2005-06-02 3M Innovative Properties Company Composes d'un anneau d'imidazo substitues par oxime
AU2004293078B2 (en) * 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
TW200616604A (en) * 2004-08-26 2006-06-01 Nicholas Piramal India Ltd Nitric oxide releasing prodrugs containing bio-cleavable linker
JP2009528989A (ja) * 2006-02-17 2009-08-13 ファイザー・リミテッド Ｔｌｒ７変調剤としての３−デアザプリン誘導体

Also Published As

Publication number Publication date
BRPI0615250A2 (pt) 2011-05-10
EP1924581A1 (fr) 2008-05-28
KR20080031496A (ko) 2008-04-08
US20120035209A1 (en) 2012-02-09
TNSN08099A1 (fr) 2009-07-14
ECSP088225A (es) 2008-03-26
WO2007028129A1 (fr) 2007-03-08
RS20080128A (sr) 2009-05-06
US20100152230A1 (en) 2010-06-17
AU2006287157A1 (en) 2007-03-08
CA2620933A1 (fr) 2007-03-08
JP2009507036A (ja) 2009-02-19
NO20081393L (no) 2008-05-28
EA200800396A1 (ru) 2008-08-29
IL189262A0 (en) 2008-06-05
CR9781A (es) 2008-03-26
JP4584335B2 (ja) 2010-11-17
MX2008002414A (es) 2008-03-27
CN101253173A (zh) 2008-08-27
SV2009002832A (es) 2009-02-19
ZA200801645B (en) 2010-08-25

Similar Documents

Publication Publication Date Title
TNSN08099A1 (fr) 1-h-imidazopyridines a substituant hydroxy et procedes
WO2019035864A8 (fr) Activateurs de la pyruvate kinase destinés à être utilisés dans le traitement de troubles sanguins
MY161812A (en) Substituted imidazo ring systems and methods
SG149829A1 (en) Pyrazolopyridines and analogs thereof
MA64509B1 (fr) Composés hétérocycliques utilisés comme immunomodulateurs
MA64121B1 (fr) Composés hétérocycliques utilisés comme immunomodulateurs
TW200639172A (en) Pyrazolopyridines and analogs thereof
MA32070B1 (fr) Dérivés hétérocycliques réunis par fusion et procédés d'utilisation associés
BRPI0414856A (pt) imidazoquinolinas alcóxi-substituìdas
MA31754B1 (fr) Cis-imidazolines chirales
MA34308B1 (fr) Triazolopyridines substituées
MA35109B1 (fr) Derives de nucleoside 2-substitues et procedes d'utilisation de ceux-ci pour le traitement de maladies virales
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MA27569A1 (fr) Derives de pyrrolo-pyrazole substitues servant d'inhibiteurs de kinases
MA33734B1 (fr) N1-pyrazolospirocétone inhibitrices d'acétyl-coa carboxylase
MA47447B1 (fr) 2-hétéroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides pour le traitement du cancer
MA27347A1 (fr) Inhibiteurs de protease du vih, compositions les contenant, leurs utilisations pharmaceutiques et matieres pour leur synthese
MA40290A1 (fr) Agents immunorégulateurs
MXPA05009488A (es) 1-amino 1h-imidazoquinolinas.
MA29932B1 (fr) Inhibiteurs de la proteine d'activation de la 5-lipoxygenase (flap)
MA31881B1 (fr) Dérivés de n-(arylamino)arylsulfonamide comprenant des polymorphes en tant qu'inhibiteurs de mek ainsi que compositions, procédés d'utilisation et procédés de préparation de ceux-ci
BRPI0413998A (pt) imidazoquinolinas arilóxi e arilalquilenóxi substituìdas
WO2007106854A3 (fr) 1h-imidazonaphthyridines hydroxy et alcoxy substituées, et procédés associés
MA30352B1 (fr) Pyridine [3,4-b] pyrazinones
TW200510412A (en) Oxime substituted imidazo-containing compounds